Table 1. Statistically significant clusters (FDC1) from WIFA-Seq for 37 patients with GBM.

Chr	Start	End	Score	# of patients	P-values	Genes
7	53982101	56449401	504208.00	25	0.00	EGFR
9	19626001	29431601	−156930.60	26	0.00	CDKN2A|CDKN2B
12	56919201	59971201	119463.40	11	0.00	CDK4
1	203277901	205825501	110989.60	7	0.01	MDM4
4	52663201	56488401	97355.73	7	0.00	PDGFRA
12	69038101	69416901	52436.32	6	0.01	MDM2
6	106784301	108840801	49466.33	4	0.04
10	88984001	90359501	−13045.48	14	0.06	PTEN
18	25736501	27397901	−10002.23	9	0.01
19	34288701	39415601	9068.60	7	0.00
12	16587901	21884101	−8619.56	8	0.07
6	162272701	164169001	−7932.19	3	0.03	PARK2|QKI
2	233933901	235859501	−7083.54	2	0.00
15	35156501	37062401	−6761.21	14	0.06
11	66176001	67434201	6164.80	2	0.01
16	4027401	5129501	6045.22	2	0.02
16	84363801	85714601	5984.56	4	0.02
14	33407901	35914401	−5872.19	3	0.04	NPAS3*
21	9411001	11188101	−5284.48	23	0.00
7	153749801	156394701	−4123.94	5	0.02
8	1902201	2776501	−3727.91	3	0.01
4	49095601	49660001	−3547.28	4	0.02
20	58229601	58514701	−2890.01	16	0.00
20	3684901	4517301	2882.16	2	0.04
8	43027601	43838801	1316.54	2	0.01

Clusters are ordered by cluster scores. Among the genes in the clusters, some genes related to GBM are specified. Previously known GBM genes in the silver standard are shown without asterisks.